NDC 83634-115-41 - Vancomycin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83634-115
- Requested NDC
- 83634-115-41
- Package NDCs from labels
- 83634-115-41, 83634-115-30
- Manufacturer
- Avenacy, LLC
- Effective date
- 2026-07-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vancomycin Hydrochloride - Avenacy, LLC | Avenacy, LLC | 2026-07-31 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | Slate Run Pharmaceuticals, LLC | 57f58371-3ce6-4983-89df-acba33d1139a | 2026-05-15 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | GLENMARK PHARMACEUTICALS INC., USA | 74056e26-57fd-448e-af76-edbccfc3efb7 | 2026-04-07 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Civica, Inc | 3e041ec6-811b-4f26-9303-959cb09d5f57 | 2026-04-02 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | f2901045-904f-47bd-74a1-c561facd7f25 | 2026-04-01 | Warnings, Adverse reactions | 2049890 1807518 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | c9ea31ec-4c26-452f-b07b-c5f894212cd5 | 2026-04-01 | Warnings, Adverse reactions | 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | ae6efaaf-37eb-4510-ba71-5f3dc3abdbd3 | 2026-03-31 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Plano Pharmaceuticals Inc. | 4983e3c8-e0f2-b366-e063-6394a90a9557 | 2026-03-25 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | 27d06545-1af0-4dcd-926d-58d4a9492ec3 | 2026-03-02 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | 3707ad2e-5c82-4111-a370-e518e5e7e4c5 | 2026-03-02 | Warnings, Adverse reactions | 71WO621TJD |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | 6OZP39ZG8H |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Plano Pharmaceuticals Inc. | 4983f60c-0f7b-d427-e063-6394a90a838c | 2026-02-24 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ab658fbd-68ea-4275-84b1-c3361c860bd3 | 2026-02-11 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Gland Pharma Limited | 00946db3-d6c5-4534-a870-1ec6e63eda43 | 2026-01-30 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | XGen Pharmaceuticals DJB, Inc. | 4239165c-4c15-b78e-e063-6294a90ae6af | 2025-12-31 | Warnings, Adverse reactions | 2049890 2049888 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | GLENMARK PHARMACEUTICALS INC., USA | 0543b2b5-b1c7-4ad6-b38c-3be0086f0e06 | 2025-12-23 | Warnings, Adverse reactions | 2049890 1807518 2049888 71WO621TJD |
| Vancocin | VANCOMYCIN HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | a078d9c2-f89c-4f9f-8ded-60ffb2983c3f | 2025-12-22 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Redpharm Drug | 3745b502-c222-e307-e063-6394a90a697e | 2025-12-18 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Strides Pharma Science Limited | fac438bd-e08f-438d-ab64-426fc5c5450e | 2025-11-28 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Henry Schein, Inc. | 1bda7fa4-fdee-410a-a216-02cfbf91632f | 2025-11-07 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 2c355037-6a1e-4846-872a-471ccbdc8d54 | 2025-10-31 | Warnings, Adverse reactions | 2049890 1807518 2049888 71WO621TJD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.